BETA - What imaging modalities are used to detect lytic and focal lesions?

This video explains the essential role of imaging in diagnosing and monitoring multiple myeloma, with a focus on understanding the difference between lytic lesions and focal lesions and how different imaging technologies help detect them.

The video begins by defining lytic lesions as areas where myeloma cells have damaged and weakened the bone, creating visible “holes” in the skeleton that can lead to pain and fractures. In contrast, focal lesions are clusters of myeloma cells within the bone marrow that may appear before actual bone destruction occurs. These lesions are often detected earlier through advanced imaging techniques like MRI and PET scans.

Viewers learn which imaging tools are best suited for different purposes. X-rays and CT scans are highlighted as the best methods for detecting lytic lesions because they clearly show structural bone damage. MRI scans are explained as highly sensitive for identifying focal lesions and abnormal bone marrow activity, while PET/CT scans combine metabolic and structural imaging to show both active myeloma cells and associated bone destruction.

The video also discusses why identifying focal lesions is important, particularly in smoldering multiple myeloma, where the presence of multiple focal lesions may signal a higher risk of progression to active disease and influence treatment decisions. In addition, it explains how imaging can help monitor response to therapy over time, even though destructive lytic lesions themselves often do not fully heal or disappear on scans.

Finally, the video reviews how treatments such as bone-strengthening medications and radiation therapy are used to reduce pain, lower fracture risk, and protect bone health. Overall, it provides a practical overview of how different imaging methods work together to help physicians diagnose disease, assess progression risk, monitor treatment response, and guide care for patients with multiple myeloma.